Results 131 to 140 of about 1,955,704 (153)

The auxiliary diagnostic performance of creation tuberculin skin test for mycobacterium tuberculosis compared with QuantiFERON-TB Gold Plus: A diagnostic accuracy study.

Diagnostic microbiology and infectious disease
BACKGROUND For bacteriologically negative suspected tuberculosis, immunological testing provides important diagnostic evidence. The traditional tuberculin skin test has poor specificity.
Jin Yin, Min Yu
semanticscholar   +1 more source

A-220 Preanalytical factors contributing to indeterminate QuantiFERON-TB Gold Plus results: a showcase of data-driven root cause analysis

Clinical Chemistry
Targeted testing for tuberculosis (TB) is recommended for individuals at increased risk of TB exposure and progression to active TB. Interferon-gamma release assays (IGRA), such as QuantiFERON-TB Gold Plus (QFT-Plus), are widely used for TB ...
Mitchell Stapp, Farideh Ezzatpanah, D. Gónzalez, Rongrong Huang   +3 more
semanticscholar   +1 more source

27. GIÁ TRỊ CỦA XÉT NGHIỆM QUANTIFERON®-TB GOLD PLUS TRONG CHẨN ĐOÁN LAO TIỀM ẨN

Tạp chí Y học Cộng đồng
Mục tiêu: Xác định giá trị của xét nghiệm QuantiFERON-TB Gold Plus (QFT-Plus) trong xác định lao tiềm ẩn ở bệnh viện Thanh Nhàn. Đối tượng và phương pháp nghiên cứu: nghiên cứu mô tả trên 91 cá nhân ≥ 15 tuổi được đưa vào nhóm nghiên cứu.
Nguyễn Minh Hiện, Vương Thị Hồng Nhung, Nguyễn Thị Diễm My, Trần Khánh Chi   +3 more
semanticscholar   +1 more source

Cost-Effectiveness Analysis Comparing QuantiFERON-TB Gold Plus Test and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Immunocompetent Subjects in Colombia.

Value in Health Regional Issues
OBJECTIVES To determine the cost-effectiveness of the QuantiFERON-TB Gold Plus (QFT-Plus) test versus the tuberculin skin test in diagnosing latent tuberculosis infection in immunocompetent subjects in the context of the Colombian healthcare system ...
Cristian E. Navarro, J. Betancur
semanticscholar   +1 more source

Performance of the T-SPOT.TB test in patients with indeterminate QuantiFERON-TB Gold Plus results: proposal for an algorithm for the diagnosis of Latent Tuberculosis Infection.

Le infezioni in medicina
Latent Tuberculosis Infection (LTBI) is a state of persistent immune response to Mycobacterium tuberculosis complex antigens without clinical, radiological and microbiological signs of active disease.
Monica Pagnoncelli, M. Arosio, A. Genovesi, Gavino Napolitano, C. Farina   +4 more
semanticscholar   +1 more source

CD8+ T cell response in QuantiFERON-TB Gold Plus testing was associated with tuberculosis recurrence: a 2-year prospective study

Infectious Diseases
Background Recurrence posed an important challenge to pulmonary tuberculosis (PTB) control in China. The prospective study aimed to identify potential risk factors and to explore the value of QuantiFERON-TB Gold Plus (QFT-Plus) in identifying at-risk ...
H. Xin, Xuefang Cao, B. Feng, Yijun He, Tonglei Guo, Jiang Du, Lingyu Shen, Yuanzhi Di, Zisen Liu, Dakuan Wang, Bin Zhang, Zhanjiang Zhang, X. Guan, F. Shen, L. Guan, S. Pan, Weitao Duan, Q. Jin, Lei Gao   +18 more
semanticscholar   +1 more source

Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly

Journal of Infection and Chemotherapy, 2021
Takahiro Takazono, Kazumasa Akagi, Noriho Sakamoto   +2 more
exaly  

IL-1RA in the supernatant of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus is useful for discriminating active tuberculosis from latent infection

Journal of Infection and Chemotherapy, 2021
Atsuhisa Tamura, Akira Yamane, Maho Suzukawa   +2 more
exaly  

Comparative Results of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus Assays for Detection of Tuberculosis Infection in Clinical Samples

Journal of Clinical Microbiology, 2020
Hyon-Suk Kim, Younhee Park, Dongju Won   +2 more
exaly  

Comparison of QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold In-Tube, and T-SPOT.TB among patients with tuberculosis

Journal of Infection and Chemotherapy, 2020
Maho Suzukawa, Keita Takeda, Shigeto Tohma   +2 more
exaly